-
1رسالة جامعية
المؤلفون: Koenig, Alice
مرشدي الرسالة: Lyon, Thaunat, Olivier
مصطلحات موضوعية: Cellule Natural Killer, Rejet chronique, Missing-self, Transplantation, Inhibiteurs de mTOR, NK cell, Chronic rejection, MTOR inhibitors, 570
-
2رسالة جامعية
المؤلفون: Freis, Patricia
مرشدي الرسالة: Lyon, Ferraro-Peyret, Carole
مصطلحات موضوعية: NNE GEP, Tumeurs neuroendocrines, Stress du réticulum endoplasmique, UPR, Inhibiteurs de mTOR, GEP NEN, Neuroendocrine tumors, Endoplasmic reticulum stress, MTOR inhibitors, 616.99
-
3رسالة جامعية
المؤلفون: Gustafson, Heather Lynn
مرشدي الرسالة: Briehl, Margaret M., Rimsza, Lisa, Futscher, Bernard, Doetschman, Thomas, Lau, Serrine
مصطلحات موضوعية: Oxidative Stress, Cancer Biology, Mantle Cell Lymphoma, mTOR inhibitors
-
4مورد إلكتروني
المؤلفون: Glaviano, Antonino
المصدر: Molecular Cancer; vol 22, iss 1
مصطلحات الفهرس: AKT inhibitors, ATP-competitive mTOR inhibitors, Allosteric mTOR inhibitors, Bi-steric mTOR inhibitors, Cancer, Dual PI3K/mTOR inhibitors, Isoform-specific PI3K inhibitors, PDK1 inhibitors, PI3K/AKT/mTORC pathway, Pan PI3K inhibitors, Humans, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Signal Transduction, TOR Serine-Threonine Kinases, Neoplasms, article
-
5مورد إلكتروني
المصدر: Kimmel Cancer Center Faculty Papers
مصطلحات الفهرس: humans, male, MTOR inhibitors, mutation, perivascular epithelioid cell neoplasms, sarcoma, sirolimus, TOR serine-threonine kinases, Humans, Male, MTOR Inhibitors, Mutation, Perivascular Epithelioid Cell Neoplasms, Sarcoma, Sirolimus, TOR Serine-Threonine Kinases, Genomics, Medical Pathology, Oncology, Surgery, report
-
6مورد إلكتروني
مصطلحات الفهرس: Adenosine triphosphate (ATP), Colorectal cancer, Mitochondrial glucose metabolism, Metastasis-associated antigen 1 (MTA1), MTOR inhibitors, Article
URL:
https://repository.hkust.edu.hk/ir/Record/1783.1-128241Test https://doi.org/10.1002/advs.202300756Test http://lbdiscover.ust.hk/uresolver?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rfr_id=info:sid/HKUST:SPI&rft.genre=article&rft.issn=2198-3844&rft.volume=&rft.issue=&rft.date=2023&rft.spage=&rft.aulast=Wang&rft.aufirst=&rft.atitle=MTA1%2C+a+Novel+ATP+Synthase+Complex+Modulator%2C+Enhances+Colon+Cancer+Liver+Metastasis+by+Driving+Mitochondrial+Metabolism+Reprogramming&rft.title=ADVANCED+SCIENCETest http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=LinksAMR&SrcApp=PARTNER_APP&DestLinkType=FullRecord&DestApp=WOS&KeyUT=001027203300001Test http://www.scopus.com/record/display.url?eid=2-s2.0-85164700632&origin=inwardTest -
7مورد إلكتروني
مصطلحات الفهرس: Everolimus, host-directed therapies, latent tuberculosis infection, mTOR inhibitors, Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/10807/232291Test
info:eu-repo/semantics/altIdentifier/pmid/36671372
info:eu-repo/semantics/altIdentifier/wos/WOS:000916728100001
volume:12
issue:1
firstpage:171
lastpage:N/A
issueyear:2023
journal:ANTIBIOTICS -
8مورد إلكتروني
المؤلفون: Rajdev, Lakshmi
المصدر: Investigational new drugs; vol 40, iss 6, 1306-1314; 0167-6997
مصطلحات الفهرس: Humans, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors, Pancreatic Neoplasms, Sirolimus, Protein Kinase Inhibitors, Mechanistic Target of Rapamycin Complex 1, MTOR Inhibitors, PNET, Sapanisertib, mTORC1/2 inhibitor, Clinical Research, Cancer, Clinical Trials and Supportive Activities, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Pharmacology and Pharmaceutical Sciences, Oncology & Carcinogenesis, article
-
9مورد إلكتروني
المؤلفون: Khaddam, Sinan
المصدر: Journal of kidney cancer and VHL; vol 9, iss 1, 42-47; 2203-5826
-
10مورد إلكتروني
المؤلفون: Zhang, Ziyang
المصدر: Nature; vol 609, iss 7928, 822-828; 0028-0836
مصطلحات الفهرس: Brain, Humans, Glioblastoma, Sirolimus, Tacrolimus Binding Protein 1A, Ligands, Drug Therapy, Combination, Xenograft Model Antitumor Assays, TOR Serine-Threonine Kinases, MTOR Inhibitors, Brain Cancer, Rare Diseases, Brain Disorders, Neurosciences, Orphan Drug, Cancer, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Neurological, General Science & Technology, article